Cargando…

Comparing pharmacologic measures of tenofovir exposure in a U.S. pre-exposure prophylaxis randomized trial

It is critical to assess adherence to pre-exposure prophylaxis (PrEP) in clinical trials. The relationship between pharmacokinetic measures of PrEP adherence and other adherence measures used in PrEP trials requires further characterization. Plasma, peripheral blood mononuclear cells (PBMCs), and ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baxi, Sanjiv M., Vittinghoff, Eric, Bacchetti, Peter, Huang, Yong, Chillag, Kata, Wiegand, Ryan, Anderson, Peter L., Grant, Robert, Greenblatt, Ruth M., Buchbinder, Susan, Gandhi, Monica, Liu, Albert Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5760024/ https://www.ncbi.nlm.nih.gov/pubmed/29315307 http://dx.doi.org/10.1371/journal.pone.0190118

Ejemplares similares

Bone Mineral Density in HIV-Negative Men Participating in a Tenofovir Pre-Exposure Prophylaxis Randomized Clinical Trial in San Francisco
por: Liu, Albert Y., et al.
Publicado: (2011)

Strong Relationship between Oral Dose and Tenofovir Hair Levels in a Randomized Trial: Hair as a Potential Adherence Measure for Pre-Exposure Prophylaxis (PrEP)
por: Liu, Albert Y., et al.
Publicado: (2014)

Comparing the Novel Method of Assessing PrEP Adherence/Exposure Using Hair Samples to Other Pharmacologic and Traditional Measures
por: Baxi, Sanjiv M., et al.
Publicado: (2015)

Pre-Clinical Evaluation of Tenofovir and Tenofovir Alafenamide for HIV-1 Pre-Exposure Prophylaxis in Foreskin Tissue
por: Else, Laura, et al.
Publicado: (2022)

853. Real-World Persistency of Patients Receiving Tenofovir-Based Pre-Exposure Prophylaxis for the Prevention of HIV Infection in the US
por: Oglesby, Alan, et al.
Publicado: (2021)

Provider Adherence to Pre-exposure Prophylaxis Monitoring Guidelines in a Large Primary Care Network
por: Spinelli, Matthew A, et al.
Publicado: (2018)

Prophylaxis by doravirine-lamivudine-tenofovir disoproxil fumarate or elvitegravir-cobicistat-emtricitabine-tenofovir alafenamide after sexual exposure to HIV
por: Devred, Inès, et al.
Publicado: (2023)

The Safety of Tenofovir–Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B
por: Solomon, Marc M., et al.
Publicado: (2016)

Pre-Exposure Prophylaxis and the Promise of Combination Prevention Approaches
por: Buchbinder, Susan P., et al.
Publicado: (2011)

2272. High Interest in Doxycycline for Sexually Transmitted Infection Post-Exposure Prophylaxis (Doxy-PEP) in a Multi-city Survey of Men Having Sex With Men (MSM) Using a Social-Networking App
por: Spinelli, Matthew A, et al.
Publicado: (2018)

Acute Trigeminal Neuralgia Associated with Initiation of Emtricitabine/Tenofovir for HIV Pre-Exposure Prophylaxis
por: Van Slyke, Loraine, et al.
Publicado: (2018)

Perspectives on the utility and interest in a point-of-care urine tenofovir test for adherence to HIV pre-exposure prophylaxis and antiretroviral therapy: an exploratory qualitative assessment among U.S. clients and providers
por: Bardon, Ashley R., et al.
Publicado: (2020)

Testing a Real-Time Tenofovir Urine Adherence Assay for Monitoring and Providing Feedback to Preexposure Prophylaxis in Kenya (PUMA): Protocol for a Pilot Randomized Controlled Trial
por: Drain, Paul, et al.
Publicado: (2020)

Pre- and post-sexual exposure prophylaxis of HIV: An update
por: Marfatia, Yogesh S., et al.
Publicado: (2017)

Comparing Self-Report Pre-Exposure Prophylaxis Adherence Questions to Pharmacologic Measures of Recent and Cumulative Pre-Exposure Prophylaxis Exposure
por: Blumenthal, Jill, et al.
Publicado: (2019)

Tenofovir Pre-exposure Prophylaxis for Pregnant and Breastfeeding Women at Risk of HIV Infection: The Time is Now
por: Mofenson, Lynne M.
Publicado: (2016)

Use of Tenofovir Alafenamide Fumarate for HIV Pre-Exposure Prophylaxis and Incidence of Hypertension and Initiation of Statins
por: Rivera, Adovich S., et al.
Publicado: (2023)

Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis
por: Solomon, Marc M., et al.
Publicado: (2014)

1551. Changes in Glomerular Filtration Rate after Switching from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide Fumarate for HIV Pre-exposure Prophylaxis
por: Rivera, Adovich, et al.
Publicado: (2023)

Nevirapine Concentration in Hair Samples Is a Strong Predictor of Virologic Suppression in a Prospective Cohort of HIV-Infected Patients
por: Baxi, Sanjiv M., et al.
Publicado: (2015)

Short- and Long-Term Pharmacologic Measures of HIV Pre-exposure Prophylaxis Use Among High-Risk Men Who Have Sex With Men in HPTN 067/ADAPT
por: Velloza, Jennifer, et al.
Publicado: (2019)

Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01
por: Huang, Yunda, et al.
Publicado: (2023)

The Tenofovir Pre-Exposure Prophylaxis Trial in Thailand: Researchers Should Show More Openness in Their Engagement with the Community
por: Chua, Arlene, et al.
Publicado: (2005)

Frequency of Hepatitis B Virus Resistance Mutations in Women Using Tenofovir Gel as Pre-Exposure Prophylaxis
por: Baxter, Cheryl, et al.
Publicado: (2019)

Topical Tenofovir Pre-exposure Prophylaxis and Mucosal HIV-Specific Fc-Mediated Antibody Activities in Women
por: Fisher, Kimone Leigh, et al.
Publicado: (2020)

HIV pre-exposure prophylaxis for women
por: Sheth, Anandi N, et al.
Publicado: (2016)

Toward Greater Pre-exposure Prophylaxis Equity: Increasing Provision and Uptake for Black and Hispanic/Latino Individuals in the U.S.
por: Bonacci, Robert A., et al.
Publicado: (2021)

Acceptability of injectable pre-exposure prophylaxis among people who inject drugs in three urban U.S. settings
por: King, Adrian R., et al.
Publicado: (2022)

A Qualitative Systematic Literature Review of the Role of U.S. Pharmacists in Prescribing Pre-Exposure Prophylaxis (PrEP)
por: Cernasev, Alina, et al.
Publicado: (2023)

Evaluation of tolerability with the co-formulation elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate for post-HIV exposure prophylaxis
por: Valin, Nadia, et al.
Publicado: (2016)

936 Tolerability, Adherence and Completion of New Occupational HIV Post-Exposure Prophylaxis Regimens (Tenofovir + Emtricitabine and Raltegravir)
por: Bock, Izona, et al.
Publicado: (2014)

Tenofovir-Diphosphate as a Marker of HIV Pre-exposure Prophylaxis Use Among East African Men and Women
por: Pyra, Maria, et al.
Publicado: (2019)

Acute Weight Gain After Switch to Emtricitabine/Tenofovir Alafenamide for Human Immunodeficiency Virus Pre-Exposure Prophylaxis
por: Selvaraj, Shailendra V, et al.
Publicado: (2020)

Preclinical Considerations for Long-acting Delivery of Tenofovir Alafenamide from Subdermal Implants for HIV Pre-exposure Prophylaxis
por: Gunawardana, Manjula, et al.
Publicado: (2022)

Exposure of the U.S. population to lead, 1991-1994.
por: Pirkle, J L, et al.
Publicado: (1998)

Exposure of U.S. workers to environmental tobacco smoke.
por: Hammond, S K
Publicado: (1999)

Cadmium Exposure and Neurodevelopmental Outcomes in U.S. Children
por: Ciesielski, Timothy, et al.
Publicado: (2012)

Exposure of the U.S. population from occupational radiation
por: National Council on Radiation Protection and Measurements. Bethesda, MD
Publicado: (1989)

Poultry Consumption and Arsenic Exposure in the U.S. Population
por: Nigra, Anne E., et al.
Publicado: (2016)

Exposure to untrustworthy websites in the 2016 U.S. election
por: Guess, Andrew M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_itdeudcoie7p8bl1m7grse29e9